Abstract
Gynecological cancers arising in the cervix, corpus, ovaries, or fallopian tubes, like rectal and rectosigmoid cancers, not infrequently involve the vagina, paravagina, and perineum as well as the true pelvis beyond these structures, either by direct continuity spread or by “skip” lymphatic retrograde metastasis. The involvement occurs usually when disease persists or recurs following definitive surgical, radiotherapeutic, or combined treatment. This extensive recurrent vaginal-pelvic disease is in most patients not amenable even to exenteration. External radiation modalities also are limited by the intense vulval-anal skin reactions that appear if curative doses are attempted. Furthermore, conventional radium needle implants do not provide a technic of delivering cancerocidal doses to large inaccessible volumes of cancer. In 1958 the author modified the “Henschke” iridium-192 removable nylon ribbon interstitial implant technic (1) and developed the “blind-end” method applicable to carcinoma of the rectum...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.